台股 » 王子製藥 » 個股財報 » 每月營收

王子製藥

(6935)
  • 股價
    29.20
  • 漲跌
    ▼0.33
  • 漲幅
    -1.12%
  • 成交量
    1
  • 產業
    興櫃 食品工業 0.00%
  • 本地時間:14:55

    0人加入追蹤

    立即追蹤

王子製藥 (6935) 財務報表-每月營收
月營收報表

因應IFRSs國際會計準則,本報表在2013年以前為「個別營收」,2013年以後為「合併營收」。

王子製藥 (6935) 月營收分析比較圖

王子製藥 (6935) 月營收報表

年度/月份營業收入(單位:千元)累計營業收入(單位:千元)
單月營收去年同月營收單月月增率單月年增率累計營收去年累計營收累積年增率
2025/11112,64250,7794.9%121.8%954,326616,98954.7%
2025/10107,41561,4863.7%74.7%841,684566,21048.7%
2025/09103,61154,52918%90%734,269504,72445.5%
2025/0887,80057,806-7.4%51.9%630,658450,19540.1%
2025/0794,79452,5708.6%80.3%542,858392,38938.3%
2025/0687,31966,582-8.1%31.1%448,064339,81931.9%
2025/0595,02559,69722.2%59.2%360,745273,23732%
2025/0477,77560,5644.4%28.4%265,720213,54024.4%
2025/0374,50152,10944.8%43%187,945152,97622.9%
2025/0251,43537,973-17%35.5%113,444100,86712.5%
2025/0162,00962,894-15.1%-1.4%62,00962,894-1.4%
2024/1273,03674,82443.8%-2.4%690,025753,327-8.4%
2024/1150,77966,686-17.4%-23.9%616,989678,503-9.1%
2024/1061,48657,63112.8%6.7%566,210611,817-7.4%
2024/0954,52981,395-5.7%-33%504,724554,186-8.9%
2024/0857,80660,91410%-5.1%450,195472,791-4.8%
2024/0752,57054,534-21%-3.6%392,389411,877-4.7%
2024/0666,58273,27911.5%-9.1%339,819357,343-4.9%
2024/0559,69774,368-1.4%-19.7%273,237284,064-3.8%
2024/0460,56443,73016.2%38.5%213,540209,6961.8%
2024/0352,10965,34037.2%-20.2%152,976165,966-7.8%
2024/0237,97344,130-39.6%-13.9%100,867100,6260.2%
2024/0162,89456,496-15.9%11.3%62,89456,49611.3%
2023/1274,82444,10712.2%69.6%753,327712,5295.7%
2023/1166,68661,13215.7%9.1%678,503668,4221.5%
2023/1057,63157,486-29.2%0.3%611,817607,2900.7%
2023/0981,39551,26333.6%58.8%554,186549,8040.8%
2023/0860,91479,97611.7%-23.8%472,791498,541-5.2%
2023/0754,53441,993-25.6%29.9%411,877418,565-1.6%
2023/0673,27958,622-1.5%25%357,343376,572-5.1%
2023/0574,36884,41070.1%-11.9%284,064317,950-10.6%
2023/0443,73051,579-33.1%-15.2%209,696233,540-10.2%
2023/0365,34082,93448.1%-21.2%165,966181,961-8.8%
2023/0244,13036,406-21.9%21.2%100,62699,0271.6%
雷諾支持在地化零件生產 警告歐盟不要矯枉過正Anue鉅亨-16天前
記憶體晶片戰白熱化 三星Q4可望重奪DRAM龍頭Anue鉅亨-16天前
日本Q3 GDP修正後下滑2.3% 超出預期 並創2023年以來最大降幅Anue鉅亨-16天前
王子製藥 相關文章
王子製藥 相關影音